• Markets
    • icon
  • Companies
1AD · ASX

AdAlta Ltd. (ASX:1AD)

AU$0.025

 0.001 (4.167%)
ASX:Live
04/12/2023 03:05:05 PM
Near Resistance (Realtime) HALO Price Momentum HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

1AD Overview

1AD Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About 1AD

Website

AdAlta Ltd.

Telephone

N/A

Address

Description

AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The company was founded in 2007 and is headquartered in Bundoora, Australia.

1AD Price Chart

Key Stats

Market Cap

AU$11.82M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.06

Trade Value (12mth)

AU$1,984.00

1 week

14.29%

1 month

4.35%

YTD

-45.45%

1 year

-46.67%

All time high

0.375106

Key Fundamentals

EPS 3 yr Growth

-57.300%

EBITDA Margin

N/A

Operating Cashflow

-$5m

Free Cash Flow Return

-115.30%

ROIC

-109.00%

Interest Coverage

-67.20

Quick Ratio

1.30

Other Data

Shares on Issue (Fully Dilluted)

324m

HALO Sector

Healthcare

Next Company Report Date

23-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

1AD Announcements

Latest Announcements

Date Announcements

31 October 17

Conference Presentation

×

Conference Presentation

31 May 23

Change of Director's Interest Notice x 2 (TO & DF)

×

Change of Director's Interest Notice x 2 (TO & DF)

31 May 23

Change in substantial holding

×

Change in substantial holding

31 May 23

Change in substantial holding

×

Change in substantial holding

31 January 19

Investor and analyst briefing presentation

×

Investor and analyst briefing presentation

30 October 19

AusBiotech Conference Presentation

×

AusBiotech Conference Presentation

30 July 20

Investor presentation including future milestones

×

Investor presentation including future milestones

30 January 23

Quarterly Appendix 4C and Activities Report

×

Quarterly Appendix 4C and Activities Report

30 April 20

Investor Presentation

×

Investor Presentation

29 October 21

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 November 21

AGM presentations & first iCAR-T data

×

AGM presentations & first iCAR-T data

29 November 21

Results of Annual General Meeting

×

Results of Annual General Meeting

29 May 23

Investor Summit live and recorded presentation

×

Investor Summit live and recorded presentation

29 May 23

Application for quotation of securities - 1AD

×

Application for quotation of securities - 1AD

29 May 23

Top 20 Option Holders & Distribution Schedule

×

Top 20 Option Holders & Distribution Schedule

29 June 23

AD-214 clinical trial approval

×

AD-214 clinical trial approval

29 August 22

Preliminary Final Report

×

Preliminary Final Report

29 August 22

Annual Report to shareholders

×

Annual Report to shareholders

29 August 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 August 19

Annual Report to shareholders

×

Annual Report to shareholders

28 November 18

AGM Presentation

×

AGM Presentation

28 November 18

Results of Annual General Meeting 28 November 2018

×

Results of Annual General Meeting 28 November 2018

28 April 23

Quarterly Appendix 4C and Activities Report

×

Quarterly Appendix 4C and Activities Report

28 April 23

Rights Offer to fund early return to clinic and growth

×

Rights Offer to fund early return to clinic and growth

28 April 23

Proposed issue of securities - 1AD

×

Proposed issue of securities - 1AD

28 April 23

Prospectus

×

Prospectus

28 April 23

Target Market Determination

×

Target Market Determination

28 April 23

Letter to Optionholders

×

Letter to Optionholders

1AD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.1 8.4 30.3 Lock Lock Lock
     PE X Lock Lock Lock Lock 1.0 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.5 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.01 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 35.4 10.8 31.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -16.3 -27.4 -67.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.02 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 17.5 -33.6 -69.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 237 278 318 Lock Lock Lock
Basic m Lock Lock Lock Lock 237 278 318 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.7 16.5 -100.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 9 9 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -9 -8 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.4 9.3 -7.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,005.1 -782.6 N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -8 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.5 9.2 -7.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,008.6 -785.9 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -8 -7 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -1 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -6 -6 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.3 -7.7 20.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -663.6 -613.5 N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -4 -5 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 7 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -5 -4 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.8 14.0 -24.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -5.6 -4.2 N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 9 5 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 11 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 2 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 -5 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 5 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 6 5 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 6 7 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 72.5 9.5 -72.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -62.2 -56.9 -62.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -88.1 -112.7 -254.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -122.5 -89.0 -109.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -111.6 -90.6 -109.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -94.8 -61.1 -115.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -87.3 -69.4 -67.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.6 0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -64.3 -86.6 -40.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.4 2.9 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.4 2.9 1.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 64.5 81.8 62.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -179.6 -112.5 -88.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.3 0.4 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.1 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 25.4 56.2 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -1,000.2 -754.3 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -93.7 -70.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -62.2 -56.9 -62.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 2.0 4.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -88.1 -112.7 -254.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -88.1 -112.7 -254.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 1,353.0 858.7 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 1,353.0 858.7 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 10,224.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 1,353.0 858.7 -10,224.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

1AD Shortsell

Frequently Asked Questions

The current share price of AdAlta Ltd. (1AD:ASX) is AU$0.025.
The 52-week high share price for AdAlta Ltd. (1AD:ASX) is AU$0.06.
The 52-week low share price for AdAlta Ltd. (1AD:ASX)? is AU$0.02.
AdAlta Ltd. (1AD:ASX) does not pay a dividend.
AdAlta Ltd. (1AD:ASX) does not pay a dividend.
AdAlta Ltd. (1AD:ASX) does not offer franking credits.
AdAlta Ltd. (1AD:ASX) is classified in the Healthcare.
The current P/E ratio for AdAlta Ltd. (1AD:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.